הרשות הלאומית לתמחור תרופות בהודו (NPPA) פרסמה הוראות חדשות בנוגע לתמחור מקסימלי של 151 תרופות. הרשימה פורסמה ב-14 ליוני.
פרטים אודות התמחור ואת רשימת התרופות המלאה ניתן למצוא כאן
NPPA is an organization of the Government of India which was established on 29th August 1997. The Authority, interalia, has been entrusted with the task of:
– Fixation/revision of prices of pharmaceutical products (bulk drugs and formulations)
– Enforcement of provisions of the Drugs Prices Control Order (DPCO)
– Monitoring of the prices of controlled and decontrolled drugs in the country
The National Pharmaceutical Pricing Authority, the FDA/ Drugs Controller of the State, and Drugs Inspector of the District are the enforcing authorities at National / State/ District Levels respectively.
In the case of each bulk drug, which is under price control, a single maximum selling price is fixed that is applicable throughout the country. To achieve uniformity in prices of widely used formulations, the Modifications in Drug Policy envisage that there should be ceiling prices for commonly marketed standard pack sizes of price controlled formulations which would be obligatory for all, including small scale units, to follow. Powers under para 9 of DPCO, 1995 are exercised for fixation/revision of ceiling prices. The ceiling price fixed/revised by NPPA are notified in the Gazette of India (Extraordinary) from time to time. The ceiling prices are usually notified as exclusive of excise duty, local tax, etc.
The National Pharmaceutical Pricing Authority (NPPA) has fixed / revised the prices in respect of 151 formulation packs Notification / orders dated 14.6.2013. For details please find attached in the email of the Copies of Gazette Notifications for Ceiling Prices.
“In case of scheduled formulations produced or available in the market before the date of notification of ceiling price, the manufacturers shall ensure within a period of forty-five days of the date of the notification that the maximum retail price of such scheduled formulation does not exceed the ceiling price (plus local taxes as applicable).”
This means that the present formulations containing these drugs in the market (with higher price) has to be either sold out before end of July (45days) or it will have to be returned to respective manufacturers. Further developments and gazette notification for remaining products from the NLEM list is still awaited.
In Nutshell, it is thus mandatory to comply with the DPCO (Drug Price Control Order) provisions to avoid any legal complications.
Point of Contact:
Mrs. Manmohan Kaur
Dy. Director-NPPA (National Pharmaceutical Pricing Authority)
Department of Pharmaceuticals (Ministry of Chemicals and Fertilizers, GoI)
Tel: 91-011-23746791 Extn. 31